Infant circulating MicroRNAs as biomarkers of effect in fetal alcohol spectrum disorders.

Journal: Scientific reports

Volume: 11

Issue: 1

Year of Publication: 2021

Affiliated Institutions:  Department of Neuroscience and Experimental Therapeutics, Texas A&M University Health Science Center, Bryan, TX, , USA. mahnke@tamu.edu. Harvard Medical School, Boston Children's Hospital, Institutional Centers for Clinical and Translational Research, Boston, MA, , USA. Department of Neuroscience and Experimental Therapeutics, Texas A&M University Health Science Center, Bryan, TX, , USA. Departments of Pediatrics and Emergency Medicine, Institute of Human Nutrition, Columbia University Medical Center, New York, NY, , USA. Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, MI, , USA. Departments of Human Biology and of Psychiatry and Mental Health, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. Division of Biomedical Engineering, Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, MI, , USA. joseph.jacobson@wayne.edu.

Abstract summary 

Prenatal alcohol exposure (PAE) can result in cognitive and behavioral disabilities and growth deficits. Because alcohol-related neurobehavioral deficits may occur in the absence of overt dysmorphic features or growth deficits, there is a need to identify biomarkers of PAE that can predict neurobehavioral impairment. In this study, we assessed infant plasma extracellular, circulating miRNAs (miRNAs) obtained from a heavily exposed Cape Town cohort to determine whether these can be used to predict PAE-related growth restriction and cognitive impairment. PAE, controlling for smoking as a covariate, altered 27% of expressed miRNAs with clinically-relevant effect sizes (Cohen's d ≥ 0.4). Moreover, at 2 weeks, PAE increased correlated expression of miRNAs across chromosomes, suggesting potential co-regulation. In confirmatory factor analysis, the variance in expression for PAE-altered miRNAs at 2 weeks and 6.5 months was best described by three-factor models. Pathway analysis found that factors at 2 weeks were associated with (F1) cell maturation, cell cycle inhibition, and somatic growth, (F2) cell survival, apoptosis, cardiac development, and metabolism, and (F3) cell proliferation, skeletal development, hematopoiesis, and inflammation, and at 6.5 months with (F1) neurodevelopment, neural crest/mesoderm-derivative development and growth, (F2) immune system and inflammation, and (F3) somatic growth and cardiovascular development. Factors F3 at 2 weeks and F2 at 6.5 months partially mediated PAE-induced growth deficits, and factor F3 at 2 weeks partially mediated effects of PAE on infant recognition memory at 6.5 months. These findings indicate that infant miRNAs can help identify infants who will exhibit PAE-related deficits in growth and cognition.

Authors & Co-authors:  Mahnke Amanda H AH Sideridis Georgios D GD Salem Nihal A NA Tseng Alexander M AM Carter R Colin RC Dodge Neil C NC Rathod Aniruddha B AB Molteno Christopher D CD Meintjes Ernesta M EM Jacobson Sandra W SW Miranda Rajesh C RC Jacobson Joseph L JL

Study Outcome 

Source Link: Visit source

Statistics
Citations :  ACOG. Committee opinion no. 496: At-risk drinking and alcohol dependence: obstetric and gynecologic implications. Obstetrics Gynecol.118, 383–388, doi:10.1097/AOG.0b013e31822c9906 (2011).
Authors :  12
Identifiers
Doi : 1429
SSN : 2045-2322
Study Population
Male,Female
Mesh Terms
Adolescent
Other Terms
Study Design
Cohort Study,Cross Sectional Study
Study Approach
Country of Study
Publication Country
England